Onasemnogene Abeparvovec Administration via Peripherally Inserted Central Catheter: A Case Report
Onasemnogene Abeparvovec Administration via Peripherally Inserted Central Catheter: A Case Report
About this item
Full title
Onasemnogene Abeparvovec Administration via Peripherally Inserted Central Catheter: A Case Report
Author / Creator
Journal title
Children (Basel, Switzerland), 2024, Vol.11 (5)
Language
English
Formats
More information
Scope and Contents
Contents
Onasemnogene abeparvovec (OA) is the approved intravenous gene therapy for the treatment of spinal muscular atrophy (SMA). A functional copy of the human SMN1 gene was inserted into the target motor neuron cells via a viral vector, AAV9. In clinical trials, OA was infused through a peripheral venous catheter, and no data are available on central ca...
Alternative Titles
Full title
Onasemnogene Abeparvovec Administration via Peripherally Inserted Central Catheter: A Case Report
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3060374827
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3060374827
Other Identifiers
ISSN
2227-9067
E-ISSN
2227-9067
DOI
10.3390/children11050590
How to access this item
Log in as a Library member
